Results 31 to 40 of about 7,550,915 (348)
We welcome the position paper by the European Society for Medical Oncology on issues surrounding biosimilars.1 After recent approval of the first biosimilars of monoclonal antibodies (mAbs) in oncology, the input of medical oncology societies to an open ...
G. Bakalos, T. Schreitmüller
semanticscholar +1 more source
Hope in the era of precision oncology: a qualitative study of informal caregivers’ experiences
Objectives To explore informal caregivers’ perspectives on precision medicine in cancer care.Design Semi-structured interviews with the informal caregivers of people living with cancer and receiving targeted/immunotherapies.
Alex Broom+9 more
doaj +1 more source
Malnutrition is a frequent problem in cancer patients, which leads to prolonged hospitalization, a higher degree of treatment-related toxicity, reduced response to cancer treatment, impaired quality of life and a worse overall prognosis.
R. Caccialanza+9 more
semanticscholar +1 more source
Clinical practice guidelines of medical societies in Switzerland: analysis of the current state
AIM OF THE STUDY In Switzerland, clinical practice guidelines (CPGs) are not generally registered by a single central institution. Therefore, the total number and overall quality of the existing guidelines are not known.
Lukas Bachmann+2 more
doaj +1 more source
Objectives Evidence-based clinical guidelines play an important role in healthcare and can be a valuable source for quality indicators (QIs). However, the link between guidelines and QI is often neglected and methodological standards for the development ...
Jochen Schmitt+7 more
doaj +1 more source
EFSUMB Statement on Medical Student Education in Ultrasound [long version]
The European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) recommends that ultrasound should be used systematically as an easy accessible and instructive educational tool in the curriculum of modern medical schools.
V. Cantisani+15 more
semanticscholar +1 more source
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source
Radiology education in Europe: Analysis of results from 22 European countries. [PDF]
AimTo assess the state of radiology education across Europe by means of a survey study.MethodsA comprehensive 23-item radiology survey was distributed via email to the International Society of Radiology members, national radiological societies ...
Dillon, William P+6 more
core
Effects of an increase in patient copayments on medical service demands of the insured in japan [PDF]
Objectives:To examine quantitatively the effects of an increase in patient copayments from 10% to 20% on the demand for medical services in Japan. Methods: The subjects of the study were the employees insured by the 1,797 health insurance societies ...
Babazono, Akira+5 more
core +1 more source